Yousif Capital Management LLC Sells 2,309 Shares of Astrana Health, Inc. $ASTH

Yousif Capital Management LLC cut its holdings in Astrana Health, Inc. (NASDAQ:ASTH) by 14.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,561 shares of the company’s stock after selling 2,309 shares during the period. Yousif Capital Management LLC’s holdings in Astrana Health were worth $337,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Covestor Ltd lifted its holdings in Astrana Health by 777.6% during the first quarter. Covestor Ltd now owns 2,001 shares of the company’s stock worth $62,000 after acquiring an additional 1,773 shares during the period. AlphaQuest LLC increased its position in shares of Astrana Health by 144.2% during the 1st quarter. AlphaQuest LLC now owns 4,883 shares of the company’s stock valued at $151,000 after purchasing an additional 2,883 shares during the last quarter. US Bancorp DE increased its position in shares of Astrana Health by 21.3% during the 1st quarter. US Bancorp DE now owns 5,791 shares of the company’s stock valued at $180,000 after purchasing an additional 1,015 shares during the last quarter. Hsbc Holdings PLC bought a new stake in shares of Astrana Health during the 1st quarter worth $200,000. Finally, Strs Ohio bought a new stake in shares of Astrana Health during the 1st quarter worth $332,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ASTH has been the subject of several research reports. Weiss Ratings restated a “hold (c-)” rating on shares of Astrana Health in a research report on Wednesday, October 8th. Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Friday, October 10th. Four equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $47.40.

Astrana Health Price Performance

NASDAQ ASTH opened at $33.16 on Friday. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.52. The company has a market cap of $1.86 billion, a PE ratio of 65.02, a price-to-earnings-growth ratio of 0.90 and a beta of 0.80. Astrana Health, Inc. has a 52 week low of $21.20 and a 52 week high of $60.99. The firm’s 50-day simple moving average is $30.01 and its two-hundred day simple moving average is $27.94.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Wednesday, January 10th. The company reported $0.50 earnings per share (EPS) for the quarter. The company had revenue of $317.00 million for the quarter. Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. Research analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.